We and others have shown that Met tyrosine kinase, a high affinity receptor for HGF, is often overexpressed in ovarian carcinomas and cancer cell lines [4, 11], and constitutive activation of the Met receptor through paracrine/autocrine mechanisms has been observed with progressive neoplastic changes [11-13]. This evidence concerns the gene HGF and cancer.